Share ownership Incyte Corporation

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			After hours 00:39:17
108.53 ^USD	+0.65%		107.66	-0.81%

06-11	Guggenheim Lifts Price Target on Incyte to $136 From $130, Maintains Buy Rating	MT
06-11	William O'Neil Initiates Incyte at Buy	MT

Share class: Incyte Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	199,782,155	196,003,273 ( 98.11 %)	0	98.11 %

Major shareholders: Incyte Corporation

Name	Stocks	%	Valuation
Baker Bros. Advisors LP 15.54 %	31,040,041	15.54 %	3 003 M $
Baker Bros. Advisors LP 15.39 %	30,744,412	15.39 %	2 974 M $
BlackRock Advisors LLC 7.293 %	14,570,131	7.293 %	1 410 M $
Dodge & Cox 6.133 %	12,252,356	6.133 %	1 185 M $
Vanguard Capital Management LLC 5.471 %	10,930,066	5.471 %	1 057 M $
STATE STREET CORPORATION 4.826 %	9,641,384	4.826 %	933 M $
Vanguard Portfolio Management LLC 3.884 %	7,759,183	3.884 %	751 M $
AQR Capital Management LLC 2.907 %	5,807,930	2.907 %	562 M $
Geode Capital Management LLC 2.354 %	4,703,184	2.354 %	455 M $
BlackRock Life Ltd. 2.007 %	4,010,584	2.007 %	388 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	107.47%
Others	6.85%
State Street Corp.	4.83%
Individuals	0.87%
SEI Investments Co.	0.38%
Schweizerische Nationalbank	0.25%
Sumitomo Mitsui Trust Group, Inc.	0.21%
Swedbank AB	0.18%
Governments	0.13%
Manulife Financial Corp.	0.06%
Danske Bank A/S	0.04%
Northwest Bancshares, Inc. (Pennsylvania)	0.03%
Banco Bilbao Vizcaya Argentaria SA	0.02%
The Bank of Nova Scotia	0.01%
Fifth Third Bancorp	0.01%
Hennessy Advisors, Inc.	0.01%
The Allstate Corp.	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	99.85%
United Kingdom	7.39%
Canada	2.89%
Australia	2.03%
Netherlands	1.43%
France	1.15%
Sweden	1.07%
Switzerland	1%
Norway	0.98%
Individuals	0.87%
Japan	0.62%
Denmark	0.32%
Luxembourg	0.3%
Ireland	0.3%
Germany	0.26%
Italy	0.17%
South Korea	0.15%
Belgium	0.1%
Spain	0.08%
Hong Kong	0.07%
Puerto Rico	0.07%
New Zealand	0.06%
South Africa	0.04%
China	0.04%
Finland	0.03%
Czech Republic	0.02%
Austria	0.02%
Estonia	0.01%
Taiwan	0.01%
Mexico	0.01%
Liechtenstein	0.01%
Brazil	0.01%

Based on 1000 largest holdings

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).

Employees

2,844

Sector

Pharmaceuticals

More about the company